Key Statistics for Ewing Tumors
Ewing tumors (Ewing sarcomas) are not common. About 1% of all childhood cancers are Ewing tumors. About 200 children and teens are diagnosed with Ewing tumors (sarcomas) in the United States each year.
Most Ewing tumors occur in teens, but they can also affect younger children, as well as adults (mainly in their 20s and 30s).
Slightly more males than females develop these cancers. These tumors are much more common among White people, either non-Hispanic or Hispanic. This disease is very rare among African Americans, and it also seldom occurs in other racial groups.
Survival statistics for these tumors are discussed in Survival Rates for Ewing Tumors, by Stage.
Visit the for more key cancer statistics.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Cancer Society. Cancer Facts & Figures 2020. Atlanta, Ga: American Cancer Society; 2020.
Anderson ME, Dubois SG, Gebhart MC. Chapter 89: Sarcomas of bone. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
DeLaney TF, Hornicek FJ, Bahrami A. Epidemiology, pathology and molecular genetics of the Ewing sarcoma family of tumors. UpToDate. Accessed at www.uptodate.com/contents/epidemiology-pathology-and-molecular-genetics-of-the-ewing-sarcoma-family-of-tumors on October 29, 2020.
National Cancer Institute. Ewing Sarcoma Treatment (PDQ). 2020. Accessed at https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq on October 29, 2020.
Last Revised: May 25, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.